167 related articles for article (PubMed ID: 34274605)
1. Pharmacokinetic and metabolomics approach based on UHPLC-MS to evaluate therapeutic effect of lignans from S. Chinensis in alzheimer's disease.
Zhou Y; Wei M; Fan M; Liu Z; Wang A; Liu Y; Men L; Pi Z; Liu Z; Song F
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jul; 1178():122859. PubMed ID: 34274605
[TBL] [Abstract][Full Text] [Related]
2. Systematically Characterize the Anti-Alzheimer's Disease Mechanism of Lignans from
Wei M; Liu Y; Pi Z; Li S; Hu M; He Y; Yue K; Liu T; Liu Z; Song F; Liu Z
Molecules; 2019 Mar; 24(7):. PubMed ID: 30934777
[TBL] [Abstract][Full Text] [Related]
3. Urinary and plasmatic metabolomics strategy to explore the holistic mechanism of lignans in S. chinensis in treating Alzheimer's disease using UPLC-Q-TOF-MS.
Wei M; Liu Z; Liu Y; Li S; Hu M; Yue K; Liu T; He Y; Pi Z; Liu Z; Song F
Food Funct; 2019 Sep; 10(9):5656-5668. PubMed ID: 31433414
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamic and urinary metabolomics studies on the mechanism of Schisandra polysaccharide in the treatment of Alzheimer's disease.
Liu Y; Liu Z; Wei M; Hu M; Yue K; Bi R; Zhai S; Pi Z; Song F; Liu Z
Food Funct; 2019 Jan; 10(1):432-447. PubMed ID: 30623955
[TBL] [Abstract][Full Text] [Related]
5. An integrated strategy using LC-MS/MS combined with
Fu J; Zhang H; Liu S; Wu J; Zhang Y; Gao Y; Song F; Qin Y; Hu X; Liu Z
Food Funct; 2021 Oct; 12(19):8932-8945. PubMed ID: 34606559
[No Abstract] [Full Text] [Related]
6. A UPLC-TOF/MS-based metabolomics study of rattan stems of Schisandra chinensis effects on Alzheimer's disease rats model.
Yang BY; Tan JY; Liu Y; Liu B; Jin S; Guo HW; Kuang HX
Biomed Chromatogr; 2018 Feb; 32(2):. PubMed ID: 28664556
[TBL] [Abstract][Full Text] [Related]
7. Development of a UFLC-MS/MS method for simultaneous determination of six lignans of Schisandra chinensis (Turcz.) Baill. in rat plasma and its application to a comparative pharmacokinetic study in normal and insomnic rats.
Wei B; Li Q; Su D; Fan R; Zhao L; Geng L; He B; Chen X; Jia Y; Bi K
J Pharm Biomed Anal; 2013 Apr; 77():120-7. PubMed ID: 23416367
[TBL] [Abstract][Full Text] [Related]
8. Comparative pharmacokinetic study of the components in Alpinia oxyphylla Miq.-Schisandra chinensis (Turcz.) Baill. herb pair and its single herb between normal and Alzheimer's disease rats by UPLC-MS/MS.
Qi Y; Cheng X; Jing H; Yan T; Xiao F; Wu B; Bi K; Jia Y
J Pharm Biomed Anal; 2020 Jan; 177():112874. PubMed ID: 31542420
[TBL] [Abstract][Full Text] [Related]
9. UFLC-MS/MS method for simultaneous determination of six lignans of Schisandra chinensis (Turcz.) Baill. in normal and insomniac rats brain microdialysates and homogenate samples: towards an in-depth study for its sedative-hypnotic activity.
Wei B; Li Q; Fan R; Su D; Ou X; Chen K; Chen X; Jia Y; Bi K
J Mass Spectrom; 2013 Apr; 48(4):448-58. PubMed ID: 23584938
[TBL] [Abstract][Full Text] [Related]
10. Metabolomics study of the therapeutic mechanism of Schisandra Chinensis lignans in diet-induced hyperlipidemia mice.
Sun JH; Liu X; Cong LX; Li H; Zhang CY; Chen JG; Wang CM
Lipids Health Dis; 2017 Aug; 16(1):145. PubMed ID: 28764799
[TBL] [Abstract][Full Text] [Related]
11. Untargeted metabolomics reveals intervention effects of wine-processed Schisandra chinensis polysaccharide on Alzheimer's disease mice.
Wu L; Guo X; Gao Y; Yu W; Qin W; Kuang H; Su Y
Int J Biol Macromol; 2024 May; 267(Pt 1):130804. PubMed ID: 38565361
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of lignans and their metabolites derived from Schisandra chinensis and vinegar Schisandra chinensis in rats’ plasma, bile, urine and faeces based on UHPLC-QTOF/MS].
Su LL; Cheng X; Ji JD; Wang LJ; Ding XY; Lu TL; Mao CQ; Zhang J
Yao Xue Xue Bao; 2016 Oct; 51(10):1600-8. PubMed ID: 29932608
[TBL] [Abstract][Full Text] [Related]
13. Metabolic mapping of Schisandra chinensis lignans and their metabolites in rats using a metabolomic approach based on HPLC with quadrupole time-of-flight MS/MS spectrometry.
Wang J; Jiang B; Shan Y; Wang X; Lv X; Mohamed J; Li H; Wang C; Chen J; Sun J
J Sep Sci; 2020 Jan; 43(2):378-388. PubMed ID: 31625256
[TBL] [Abstract][Full Text] [Related]
14. Metabolomics study of the therapeutic mechanism of
Sun J; Jing S; Jiang R; Wang C; Zhang C; Chen J; Li H
Clin Interv Aging; 2018; 13():829-841. PubMed ID: 29750025
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous determination of nine lignans from Schisandra chinensis extract using ultra-performance liquid chromatography with tandem mass spectrometry in rat plasma, urine, and gastrointestinal tract samples: application to the pharmacokinetic study of Schisandra chinensis.
Kim YJ; Lee HJ; Kim CY; Han SY; Chin YW; Choi YH
J Sep Sci; 2014 Oct; 37(20):2851-63. PubMed ID: 25113775
[TBL] [Abstract][Full Text] [Related]
16. An integrated strategy for ascertaining quality marker of Schisandra chinensis (Turcz.) Baill based on correlation analysis between depression-related monoaminergic metabolites and chemical components profiling.
Zhang Y; Lv X; Liu R; Zhang M; Liu H; Gao H; Zhang Q; Xu H; Li Q; Bi K
J Chromatogr A; 2019 Aug; 1598():122-131. PubMed ID: 31047662
[TBL] [Abstract][Full Text] [Related]
17. Mass spectrometry-based urinary metabolomics for exploring the treatment effects of Radix ginseng-Schisandra chinensis herb pair on Alzheimer's disease in rats.
Wang A; Pi Z; Liu S; Zheng Z; Liu Z; Song F
J Sep Sci; 2021 Aug; 44(16):3158-3166. PubMed ID: 34110709
[TBL] [Abstract][Full Text] [Related]
18. Explore the Therapeutic Composition and Mechanism of Schisandra chinensis-Acorus tatarinowii Schott on Alzheimer's Disease by Using an Integrated Approach on Chemical Profile, Network Pharmacology, and UPLC-QTOF/MS-Based Metabolomics Analysis.
Chen J; Hao W; Zhang C; Cui M; Sun Y; Zhang Y; Wang J; Mou T; Gu S; Zhao T; Wei B
Oxid Med Cell Longev; 2022; 2022():6362617. PubMed ID: 35860432
[TBL] [Abstract][Full Text] [Related]
19. An integrated study on the comprehensive mechanism of
Fu J; Li J; Sun Y; Liu S; Song F; Liu Z
Food Funct; 2023 Jan; 14(2):734-745. PubMed ID: 36562313
[TBL] [Abstract][Full Text] [Related]
20. Raw and wine processed Schisandra chinensis attenuate anxiety like behavior via modulating gut microbiota and lipid metabolism pathway.
Song Y; Shan B; Zeng S; Zhang J; Jin C; Liao Z; Wang T; Zeng Q; He H; Wei F; Ai Z; Su D
J Ethnopharmacol; 2021 Feb; 266():113426. PubMed ID: 33007392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
